Search

Your search keyword '"Stubbs, Matthew"' showing total 425 results

Search Constraints

Start Over You searched for: Author "Stubbs, Matthew" Remove constraint Author: "Stubbs, Matthew"
425 results on '"Stubbs, Matthew"'

Search Results

4. Characterisation of Immune Thrombotic Thrombocytopenic Purpura utilising deep phenotyping and genotyping via genome wide association study

8. A Vindication of Monsters: Essays on Mary Wollstonecraft and Mary Shelley

10. Supporting Law Students' Skills Development Online--A Strategy to Improve Skills and Reduce Student Stress?

11. HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression

12. Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced Differentiation

13. Real-world experience with caplacizumab in the management of acute TTP

14. Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase δ Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy

16. Table S2 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia

17. Figure S4 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia

18. Data from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia

19. 'Finally an Academic Approach That Prepares You for the Real World': Simulations for Human Rights Skills Development in Higher Education

22. Germline mutations in the transcription factor IKZF5 cause thrombocytopenia

25. Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndrome

28. Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndrome

29. Cancelled operations: a 7-day cohort study of planned adult inpatient surgery in 245 UK National Health Service hospitals

34. Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells

41. Abstract CT243: Clinical trial simulation to inform dose selection of zilurgisertib, an ALK2 inhibitor, in patients with anemia due to myelofibrosis (MF)

42. Abstract 5162: Discovery of INCB098377: a potent inhibitor of phosphoinositide 3-kinase gamma (PI3Kγ)

43. Data from A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms

44. Supplementary Table 1 from A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms

45. Supplementary Figures from A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms

46. Supplementary Table 2 from A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms

47. Supplemental data from BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia

48. Supplementary Tables S1-S3 and Supplementary Figures S1-S6 from Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL

49. Supplemental Data from The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination Strategies

Catalog

Books, media, physical & digital resources